ADVERTISEMENT

CorePeak Nutrition

corepeaknutrition.shop · Website policies & merchant information

References & Disclosures

Last updated: September 13, 2026

Evidence status

No product-specific clinical study has been supplied or verified for the claims previously appearing on the page. Unsupported efficacy claims have been removed from its text. This website does not describe Arialief as clinically proven to treat neuropathy.

The ingredient studies below are separate from merchant information and advertising requirements. Merchant policies and platform rules are not scientific evidence of effectiveness or endorsements.

Neuropathy symptom information

The advertorial links to the NINDS overview of pain and the NIDDK overview of diabetic neuropathy for general medical background. These sources do not evaluate or endorse Arialief and do not substantiate symptom-relief claims for this product.

Scientific studies on individual ingredients

These selected human trials concern individual ingredients or related formulations. They do not test the finished Arialief formula. Findings include positive, mixed and negative results; read the advertorial's study summaries and limitations alongside the original publications. Research doses are not usage instructions.

The producer's page mentions PEA, absent from the panel supplied for the advertorial. The current formula and individual ingredient doses need confirmation from the merchant.

  1. Magnesium: Pickering et al. (2011), Magnesium Research. Magnesium chloride, not glycinate; no significant between-group pain benefit. Original study, PMID 21659058.
  2. Alpha-lipoic acid: Ziegler et al. (2006), Diabetes Care, SYDNEY 2. Short-term symptom findings. Original study, PMID 17065669.
  3. Alpha-lipoic acid: Ziegler et al. (2011), Diabetes Care, NATHAN 1. No significant primary outcome benefit over four years. Original study, PMID 21775755.
  4. Butcher's broom: Vanscheidt et al. (2002), Arzneimittelforschung. Chronic venous insufficiency, not neuropathy. Original study, PMID 12040966.
  5. Carnitine: Sima et al. (2005), Diabetes Care. Acetyl-L-carnitine, a different form from listed L-carnitine. Original trial analysis, PMID 15616239.
  6. Turmeric-related research: Asadi et al. (2019), Complementary Therapies in Medicine. Nanocurcumin, not ordinary turmeric extract. Original study, PMID 30935539.
  7. Turmeric-related research: Mansour et al. (2025), Nutrition Journal. Later nanocurcumin trial without significant neuropathy benefit. Original study, PMID 40682175.
  8. Coenzyme Q10: Amini et al. (2022), European Journal of Clinical Pharmacology. Added to pregabalin, not tested as a stand-alone treatment. Original study, PMID 36273066.
  9. PEA, formula unconfirmed: Emily Pickering et al. (2022), Inflammopharmacology. A specific PEA formulation, not Arialief. Original study, PMID 36057884.

PubMed indexing is not an endorsement by NIH. These references do not substantiate symptom-relief claims for the finished Arialief product.

Merchant sources

Advertising transparency

Revcontent's landing-page policies explain disclosure and claim-substantiation requirements. Our Disclaimer explains the promotional nature of this website.

Source limitations

Sources were checked on September 13, 2026. Policies may change and contain inconsistent deadline language. Confirm purchase-specific terms with the merchant. Generic ingredient research has not been used as a substitute for evidence about the finished formula.